Peptide COAs
Tesamorelin
68 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.
Public certificates
Approved community and directory-linked COAs only.
- Tesamorelin
American Peptides · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.9% purity · Doc 92
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA80Solid - Tesamorelin
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.78% purity · Doc 95
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - Tesamorelin
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.47% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns79Solid - Tesamorelin
Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.78% purity · Doc 92
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA79Solid - Tesamorelin
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.19% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - Tesamorelin + Tesamorelin (10mg)
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - Tesamorelin
American Peptide Research · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation77Solid - Tesamorelin
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.19% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - Tesamorelin
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.19% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - Tesamorelin
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.19% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - Tesamorelin
American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.19% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns77Solid - Tesamorelin + Tesamorelin 10mg
Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.62% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - Tesamorelin + Tesamorelin 10mg
Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.93% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - Tesamorelin
Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.87% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - Tesamorelin
Blank Peptides · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation76Solid - Tesamorelin
Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.08% purity · Doc 62
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - Tesamorelin
Blank Peptides · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - Tesamorelin
Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.37% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns76Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.8% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 62
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.713% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 92
Document structure and test panels align with what we expect from authentic lab reports.
Consistent with a legitimate COA73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 6/7 panels · 99.851% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - CJC-1295 no DAC + Ipamorelin + Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.825% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.52% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.706% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.301% purity · Doc 88
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns73Solid - Tesamorelin
Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.95% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns71Solid - Tesamorelin
Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 98.29% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns71Solid - Tesamorelin
Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.511% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns71Solid - Tesamorelin
Retalux · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns71Solid - Tesamorelin
Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.82% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns71Solid - Tesamorelin
Retalux · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation71Solid - Tesamorelin + Tesamorelin 10mg
Koi Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.059% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns65Mixed signals - Tesamorelin
Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.95% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - Tesamorelin
Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 71.61% purity · Doc 68
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - Tesamorelin
Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - Tesamorelin
Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.81% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - Tesamorelin
Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - Tesamorelin
Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.7% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns63Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin + Ipamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 3/7 panels · 98.7% purity · Doc 68
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 3/7 panels · 98.7% purity · Doc 68
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.97% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.9% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.9% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns59Mixed signals - Tesamorelin
Lumira · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - Tesamorelin
Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.6% purity · Doc 92
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns58Mixed signals - Tesamorelin + Ipamorelin + Tesamorelin/Ipamorelin blend
Paramount Peptides · Sep 5, 2026 · Core panels 0% · 0/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation47Concerning - Tesamorelin + MGF + Ipamorelin
Paramount Peptides · Sep 5, 2026 · Core panels 0% · 0/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation47Concerning - TESAMORELIN
Paramount Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.15% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns47Concerning - TESAMORELIN
Paramount Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.75% purity · Doc 72
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns47Concerning - GHRP-2 + Tesamorelin + MGF + Ipamorelin
Paramount Peptides · Sep 5, 2026 · Core panels 0% · 0/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation47Concerning - Tesamorelin + Ipamorelin + Tesamorelin/Ipamorelin blend
Paramount Peptides · Sep 5, 2026 · Core panels 0% · 0/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation47Concerning - Tesamorelin + Ipamorelin
Paramount Peptides · Sep 5, 2026 · Core panels 0% · 0/7 panels · Doc 45
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation47Concerning
Community-sourced
Help build the COA record
PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.
Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.
Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.
Upload a COA
Scan a certificate of analysis in the app. Public shares go through review before the market.
List / claim a peptide brand
Apply to list or claim your vendor profile. Listings stay unpublished until PeptIQ approves them.
Claim / list a testing laboratory
Third-party peptide testing labs (HPLC, endotoxin, etc.) can claim or request a directory presence.
See brand trust & reputation
Browse vendor trust scores and legitimacy from moderator-approved public COAs on the market.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.